Bio Break: Addressing Shear in Drug Delivery Device Design

Resources

Bio Break: Addressing Shear in Drug Delivery Device Design

Topic: Bio Break

In this episode of Bio Break, Joris van der Heijden and Nick Allan explore one of the most critical challenges in drug delivery device design: shear stress. When designing systems for biologics and gene therapies, avoiding shear stress is essential to ensure the viability and activity of biomolecules like proteins, antibodies, and viruses.

Joris provides a comprehensive explanation of shear, defining it as the pressure and force that can disrupt or inactivate sensitive biomolecules during fluid transport. Whether caused by abrupt fluid path changes, bubbles, or high-friction pumps, shear poses a significant risk to the efficacy of advanced therapies.

Key Takeaways from the Episode

  • Understanding Shear Stress: Shear occurs when fluid is forced through abrupt changes in its path or exposed to uncontrolled movement. For biologics, shear can lead to molecule clustering or inactivation, rendering treatments ineffective.
  • Design Solutions to Reduce Shear:
    • Optimize Fluid Pathways: Use simulation tools like computational fluid dynamics (CFD) to identify and eliminate areas with abrupt fluid movement. Rounded pathways and smoother transitions help minimize turbulence and pressure.
    • Low-Shear Pumps: Select pumps specifically designed to handle biomolecules gently, preserving their activity and integrity.
  • Testing for Success: After designing a low-shear system, functional testing is critical. For example:
    • Measure the viability of cells after passing through the device.
    • Verify that antibodies, viruses, or other biomolecules remain active and effective post-delivery.

By addressing shear stress during the design phase, drug delivery devices can ensure biologics reach their target intact and active, maximizing therapeutic impact. For developers working with advanced therapies like gene therapy products, these design principles are essential to delivering cutting-edge care to patients.

This episode is a must-watch for engineers, product designers, and healthcare innovators seeking to tackle the complexities of drug delivery systems. Learn actionable strategies to refine your designs and improve the outcomes of sensitive therapeutics.

Addressing Shear in Drug Delivery Device Design

YouTube video thumbnail
Alcohol disrupting bacterial cell membrane explaining why 70 percent sanitizer kills bacteria more effectively

Nick and Nigel explore the science behind hand sanitizer formulations. They discuss how alcohol interacts with bacterial cells, why water improves its effectiveness, and what the additional ingredients in sanitizer actually do.

Scott Phillips of StarFish Medical and Peter van der Velden of Lumira Ventures speaking at a MedTech transactions webinar

Scott Phillips, CEO of StarFish Medical, sits down with Peter van der Velden, Managing General Partner at Lumira Ventures, to explore the strategic thinking behind major MedTech transactions and investments.

AI analyzing MRI brain scan using computer vision software on a medical imaging workstation

Computer vision technologies such as convolutional neural networks and vision transformers are transforming how AI analyzes medical images, each offering distinct advantages depending on the application and computing environment.

MedTech engineers discussing prototype strategy while demonstrating a medical device form prototype during product development.

Ariana and Mark explore how prototype strategy helps teams reduce technical risk and accelerate progress.